SII Investments’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-3,288
Closed -$743K 79
2017
Q4
$743K Buy
3,288
+60
+2% +$12.8K 0.08% 191
2017
Q3
$609K Buy
3,228
+368
+13% +$70K 0.03% 308
2017
Q2
$537K Buy
2,860
+147
+5% +$26.4K 0.03% 321
2017
Q1
$444K Buy
2,713
+12
+0.4% +$1.91K 0.03% 364
2016
Q4
$389K Buy
2,701
+763
+39% +$102K 0.03% 375
2016
Q3
$244K Buy
+1,938
New +$250K 0.02% 497

Other funds holding ELV

SII Investments's ELV Position: Q1 2018 in Review

SII Investments sold out of Elevance Health (ELV) in Q1 2018, closing a stake of 3,288 shares — an estimated $743K sold.

SII Investments first reported a position in ELV in Q3 2016 and held it in 6 quarters. The position peaked at $743K in Q4 2017. 924 funds tracked by Wall St. Rank hold ELV as of Q1 2018.

  • SII Investments reported no remaining Elevance Health position as of Q1 2018 after selling out during the quarter.
  • SII Investments sold 3,288 Elevance Health shares in Q1 2018, an estimated $743K.
  • SII Investments first reported a position in Elevance Health in Q3 2016 and held it in 6 quarters.
  • SII Investments's Elevance Health position peaked at $743K in Q4 2017.
  • 924 funds tracked by Wall St. Rank held Elevance Health as of Q1 2018.

Based on SII Investments's 13F filing for Q1 2018.